SNT.WAR Synektik S.A.

Healthcare Health Care Equipment & Supplies Warsaw Stock Exchange
332.80 PLN
Close of Oct 29, 2026
239.40 394.00
Market cap
PLN 2.84B
P/E
16.0x
P/B
13.16x
ROE
328.2%
Dividend yield
2.48%
Fundamental score
3.8/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is SNT.WAR undervalued?

Graham number

The Graham number of Synektik S.A. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Synektik S.A. fundamental analysis

17 of 22 checks passed

ROE 2/2

High return on equity (328.2%), above 20%.

ROA 1/1

Return on assets (124.2%) is above the industry median (-6.0%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (20.9%) is not above the 5-year average (63.3% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (20.9%) is below the industry median (24.1%).

Revenue Growth 2/2

Revenue grew 59.8% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (19.4%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE (16.0x) is above the market median (11.6x).

PE vs Industry 1/1

PE (16.0x) is below the industry median (16.1x).

PBV 0/1

Price to book (13.2x) is above the industry median (3.4x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 210.9, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.25, growth is cheap.

Dividend Yield 1/2

Dividend yield (2.5%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 8 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 68.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Synektik S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Synektik S.A.

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment,…

Full company profile